Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update
Shares of Relay Therapeutics Inc. traded higher in early premarket Tuesday. The Cambridge biotech said its top drug zovegalisib showed initial signs of shrinking lesions in patients with rare vascular anomalies. Shares changed hands at $13.47 in premarket trade at 09:03 EDT, gaining 11.3% from Monday’s $12.10 close, based on Investing.com data. That was before the regular Nasdaq open and with U.S. futures under pressure. S&P 500 futures were last off 0.4%, while Nasdaq futures were down 0.8%.